SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Amogh Agrawal, Subodh K. Samrat, Babita Agrawal, D. Lorne J. Tyrrell, Rakesh Kumar, Co-Incubation with Core Proteins of HBV and HCV Leads to Modulation of Human Dendritic Cells, Viral Immunology, 2014, 27, 8, 412

    CrossRef

  2. 2
    Miriam Skilandat, Magdalena Rowinska-Zyrek, Roland K. O. Sigel, Solution structure and metal ion binding sites of the human CPEB3 ribozyme’s P4 domain, JBIC Journal of Biological Inorganic Chemistry, 2014, 19, 6, 903

    CrossRef

  3. 3
    G. Baltayiannis, P. Karayiannis, Treatment options beyond IFNα and NUCs for chronic HBV infection: expectations for tomorrow, Journal of Viral Hepatitis, 2014, 21, 11
  4. 4
    Wei-Ping Lee, Keng-Hsin Lan, Chung-Pin Li, Yee Chao, Han-Chieh Lin, Shou-Dong Lee, Pro-apoptotic or anti-apoptotic property of X protein of hepatitis B virus is determined by phosphorylation at Ser31 by Akt, Archives of Biochemistry and Biophysics, 2012, 528, 2, 156

    CrossRef

  5. 5
    Su Jin Lee, Hee Youn Shim, Antony Hsieh, Ji Young Min, Gu hung Jung, Hepatitis B virus core interacts with the host cell nucleolar protein, nucleophosmin 1, The Journal of Microbiology, 2009, 47, 6, 746

    CrossRef

  6. 6
    Michael Nassal, Hepatitis B viruses: Reverse transcription a different way, Virus Research, 2008, 134, 1-2, 235

    CrossRef

  7. 7
    Hsiu-Ting Tsai, Tzu-Hsin Tsai, Tsong-Ming Lu, Chi-Chiang Yang, Immunopathology of Hepatitis B Virus Infection, International Reviews of Immunology, 2008, 27, 6, 427

    CrossRef

  8. 8
    Francisco Rodríguez-Frias, Rosendo Jardi, Virología molecular del virus de la hepatitis B, Enfermedades Infecciosas y Microbiología Clínica, 2008, 26, 2

    CrossRef

  9. 9
    Anna Kramvis, Michael C. Kew, Molecular characterization of subgenotype A1 (subgroup Aa) of hepatitis B virus, Hepatology Research, 2007, 37,
  10. 10
    Seong Soo Joo, Tae Joon Won, Min Jung Kim, Kwang Woo Hwang, Do Ik Lee, Interferon signal transduction of biphenyl dimethyl dicarboxylate/amantadine and anti-HBV activity in HepG2 2.2.15, Archives of Pharmacal Research, 2006, 29, 5, 405

    CrossRef

  11. 11
    Andreas Laras, John Koskinas, Evangelini Dimou, Ageliki Kostamena, Stephanos J. Hadziyannis, Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients, Hepatology, 2006, 44, 3
  12. 12
    S. Locarnini, T. Shaw, J. Dean, D. Colledge, A. Thompson, K. Li, S.M. Lemon, G.G.K. Lau, M.R. Beard, Cellular response to conditional expression of the hepatitis B virus precore and core proteins in cultured hepatoma (Huh-7) cells, Journal of Clinical Virology, 2005, 32, 2, 113

    CrossRef

  13. 13
    A. Kramvis, M. C. Kew, Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy, Journal of Viral Hepatitis, 2005, 12, 5
  14. 14
    A. Sakarev, P. Teoharov, Comparison of an in-House Qualitative PCR Assay for Detection of Hepatitis B Virus DNA with Real Time PCR using Sybr® Green I, Biotechnology & Biotechnological Equipment, 2004, 18, 3, 139

    CrossRef

  15. 15
    Peter Karayiannis, Current therapies for chronic hepatitis B virus infection, Expert Review of Anti-infective Therapy, 2004, 2, 5, 745

    CrossRef

  16. 16
    Nassim Kamar, Karine Sandres-Saune, David Ribes, Michel Duffaut, Jannick Selves, Dominique Durand, Jacques Izopet, Lionel Rostaing, Effects of long-term lamivudine therapy in renal-transplant patients, Journal of Clinical Virology, 2004, 31, 4, 298

    CrossRef

  17. 17
    Roger W.L. Godschalk, Frederik-Jan Van Schooten, Helmut Bartsch, A Critical Evaluation of DNA Adducts as Biological Markers for Human Exposure to Polycyclic Aromatic Compounds, Journal of Biochemistry and molecular biology, 2003, 36, 1, 1

    CrossRef

  18. 18
    W.S. Tan, M.R. Dyson, K. Murray, Hepatitis B Virus Core Antigen: Enhancement of Its Production in Escherichia coli, and Interaction of the Core Particles with the Viral Surface Antigen, Biological Chemistry, 2003, 384, 3

    CrossRef

  19. 19
    Takahiro Suzuki, Tetsuo Takehara, Kazuyoshi Ohkawa, Hisashi Ishida, Masahisa Jinushi, Takuya Miyagi, Yutaka Sasaki, Norio Hayashi, Intravenous injection of naked plasmid DNA encoding hepatitis B virus (HBV) produces HBV and induces humoral immune response in mice, Biochemical and Biophysical Research Communications, 2003, 300, 3, 784

    CrossRef

  20. 20
    Wang-Shick Ryu, Molecular Aspects of Hepatitis B Viral Infection and the Viral Carcinogenesis, Journal of Biochemistry and molecular biology, 2003, 36, 1, 138

    CrossRef

  21. 21
    Ruth Chin, Stephen Locarnini, Treatment of chronic hepatitis B: current challenges and future directions, Reviews in Medical Virology, 2003, 13, 4
  22. 22
    Larry G. Birkenmeyer, Viral Hepatitis: Molecular Biology, Diagnosis, Epidemiology and Control, 2003,

    CrossRef

  23. 23
    ROBERT YM CHEN, PAUL V DESMOND, STEPHEN A LOCARNINI, Emerging therapies of hepatitis B and C, Journal of Gastroenterology and Hepatology, 2002, 17,
  24. 24
    Stephen A Geller, Hepatitis B and hepatitis C, Clinics in Liver Disease, 2002, 6, 2, 317

    CrossRef

  25. 25
    Sharon Lewin, Tomos Walters, Stephen Locarnini, Hepatitis B treatment: rational combination chemotherapy based on viral kinetic and animal model studies, Antiviral Research, 2002, 55, 3, 381

    CrossRef

  26. 26
    Rosa Zampino, Salvatore Lobello, Maria Chiaramonte, Carla Venturi-Pasini, Uga Dumpis, Mark Thursz, Peter Karayiannis, Intra-familial transmission of hepatitis B virus in Italy: phylogenetic sequence analysis and amino-acid variation of the core gene, Journal of Hepatology, 2002, 36, 2, 248

    CrossRef

  27. 27
    Naazneen Moolla, Michael Kew, Patrick Arbuthnot, Regulatory elements of hepatitis B virus transcription, Journal of Viral Hepatitis, 2002, 9, 5
  28. 28
    Martin R Burda, Stephan Günther, Maura Dandri, Hans Will, Jörg Petersen, Structural and functional heterogeneity of naturally occurring hepatitis B virus variants, Antiviral Research, 2001, 52, 2, 125

    CrossRef

  29. 29
    Stephan Schaefer, Viruses, Cell Transformation and Cancer, 2001,

    CrossRef

  30. 30
    Joseph Torresi, Stephen Locarnini, Antiviral chemotherapy for the treatment of hepatitis b virus infections, Gastroenterology, 2000, 118, 2, S83

    CrossRef

  31. 31
    G. Sommer, F. van Bömmel, H. Will, Genotype-Specific Synthesis and Secretion of Spliced Hepatitis B Virus Genomes in Hepatoma Cells, Virology, 2000, 271, 2, 371

    CrossRef

  32. 32
    Pietro Pioltelli, Livio Gargantini, Edmondo Cassi, Luca Santoleri, Giorgio Bellati, Enrico Massimo Magliano, Enrico Morra, Hepatitis C virus in non-Hodgkin's lymphoma. A reappraisal after a prospective case-control study of 300 patients, American Journal of Hematology, 2000, 64, 2
  33. 33
    Huey-Lan Huang, King-Song Jeng, Cheng-Po Hu, Chiu-Ho Tsai, Szecheng J. Lo, Chungming Chang, Identification and Characterization of a Structural Protein of Hepatitis B Virus: A Polymerase and Surface Fusion Protein Encoded by a Spliced RNA, Virology, 2000, 275, 2, 398

    CrossRef

  34. 34
    Gertrud Beterams, Bettina Böttcher, Michael Nassal, Packaging of up to 240 subunits of a 17 kDa nuclease into the interior of recombinant hepatitis B virus capsids, FEBS Letters, 2000, 481, 2, 169

    CrossRef

  35. 35
    Shau-Feng Chang, Hans Jürgen Netter, Michael Bruns, Ralf Schneider, Kai Frölich, Hans Will, A New Avian Hepadnavirus Infecting Snow Geese (Anser caerulescens) Produces a Significant Fraction of Virions Containing Single-Stranded DNA, Virology, 1999, 262, 1, 39

    CrossRef

  36. 36
    U. Protzer, M. Nassal, P.-W. Chiang, M. Kirschfink, H. Schaller, Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection, Proceedings of the National Academy of Sciences, 1999, 96, 19, 10818

    CrossRef

  37. 37
    Yu. Wei, Pierre Tiollais, MOLECULAR BIOLOGY OF HEPATITIS B VIRUS, Clinics in Liver Disease, 1999, 3, 2, 189

    CrossRef

  38. 38
    P. A. Kratz, B. Bottcher, M. Nassal, Native display of complete foreign protein domains on the surface of hepatitis B virus capsids, Proceedings of the National Academy of Sciences, 1999, 96, 5, 1915

    CrossRef

  39. 39
    S. L. Ngui, R. Hallet, C. G. Teo, Natural and iatrogenic variation in hepatitis B virus, Reviews in Medical Virology, 1999, 9, 3
  40. 40
    Joseph Torresi, Stephen A Locarnini, New therapeutic strategies in the treatment of hepatitis B virus infection, Expert Opinion on Investigational Drugs, 1999, 8, 3, 289

    CrossRef

  41. 41
    T. Shaw, S. A. Locarnini, Preclinical aspects of lamivudine and famciclovir against hepatitis B virus, Journal of Viral Hepatitis, 1999, 6, 2
  42. 42
    A. Kramvis, M. C. Kew, The core promoter of hepatitis B virus, Journal of Viral Hepatitis, 1999, 6, 6
  43. 43
    William F. Carman, Christian Trautwein, HIV and the New Viruses, 1999,

    CrossRef

  44. 44
    Juan I. Esteban, Maria Martell, William F. Carman, Jordi Gómez, Origin and Evolution of Viruses, 1999,

    CrossRef

  45. 45
    Magdolna G. Sebestyén, Jon A. Wolff, Nonviral Vectors for Gene Therapy, 1999,

    CrossRef

  46. 46
    Stephan Günther, Lutz Fischer, Irmgard Pult, Martina Sterneck, Hans Will, 1999,

    CrossRef

  47. 47
    Torre, Naoumov, Clinical implications of mutations in the hepatitis B virus genome , European Journal of Clinical Investigation, 1998, 28, 8
  48. 48
    Rainer Ulrich, Michael Nassal, Helga Meisel, Detlev H. Krüger, 1998,

    CrossRef

  49. 49
    Gunhild Sommer, Stephan Günther, Martina Sterneck, Stephanie Otto, Hans Will, A New Class of Defective Hepatitis B Virus Genomes with an Internal Poly(dA) Sequence, Virology, 1997, 239, 2, 402

    CrossRef

  50. 50
    Wolfram H. Gerlich, Michael Kann, Hepatitis B, Topley and Wilson's Microbiology and Microbial Infections,